14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
ARX vs CRVL
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ARX vs CRVL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ARX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–4 Matrix Metrics)
ARX Overall Winner
6-Pillar Tally: ARX 5 – 1 CRVL
Matrix Metrics: ARX 5 – 4 CRVL
As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Corvel Corp (CRVL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas CRVL carries 42.6/100 (HOLD) at $87.34 (23.8x Forward P/E, 15.9% operating margin).
ARX
NYSE
Head-to-Head Winner
Accelerant Holdings
Insurance Agents, Brokers & Service
Market Cap
$4.3B
TTM Revenue
$2.79B
Forward P/E
21.3x
Beta / 30D Vol
-0.19β · 2% Vol
Unified Composite Score
46.9 / 100
HOLD
Tech 34.0
Fund 50.0
Flow 76.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $19.83 · SMA50: $19.80
CRVL
NASDAQ
Corvel Corp
Insurance Agents, Brokers & Service
Market Cap
$4.3B
TTM Revenue
$1.01B
Forward P/E
23.8x
Beta / 30D Vol
-0.17β · 33% Vol
Unified Composite Score
42.6 / 100
HOLD
Tech 42.0
Fund 40.0
Flow 50.0
Mom 25.9
Weinstein Technical Phase
Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.9% over 20 days), RSI 66
RSI-14: 65.7 · SMA20: $83.74 · SMA50: $78.01
6-Pillar Scorecard Institutional Category Breakdown (ARX 5 – 1 CRVL)
Columns: Metric · ARX · CRVL
1. Valuation Multiples
ARX
Forward P/E
21.3x
23.8x
Trailing P/E
27.6x
36.0x
PEG Ratio
N/M
N/M
EV / Revenue
N/M
4.3x
2. Growth & Scale
ARX
Revenue Growth (YoY)
+6.1%
+11.5%
Earnings Growth (YoY)
+800.0%
+24.1%
TTM Revenue (USD)
$2.79B
$1.01B
Market Cap
$4.3B
$4.3B
3. Profitability & Quality
CRVL
Gross Margin
62.8%
25.5%
Operating Margin
3.7%
15.9%
Net Profit Margin
5.6%
12.0%
Return on Equity (ROE)
9.2%
30.6%
4. Balance Sheet & Cash Flow
ARX
Cash Generation (TTM)
$634M
$195M EBITDA
Cash Flow Margin
22.7%
19.3% EBITDA Mgn
Net Cash / Leverage
$5.13B Net Cash
$8.54 Book/Sh · 30.6% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ARX
Options Structure Phase
CONSOLIDATION
UNCLASSIFIED
Current IV / %ile
15.7% (3rd %ile)
187.6% (100th %ile)
Put/Call OI Skew
0.01x (Call-Skewed)
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
ARX
OpEx & R&D Intensity
59.1% of Rev ($1.65B)
9.6% of Rev ($97M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Scale & Operating Efficiency Moat
Supply-Chain Role
Insurance Brokers Operator
Insurance Brokers Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ARX (5) vs CRVL (4)
Institutional Metric
ARX
CRVL
Criterion
Row Edge
Market Capitalization
Scale
$4.3B
$4.3B
Larger Scale
Tie
Trailing P/E Ratio
Valuation
27.6x
36.0x
Lower Multiple
ARX
Forward P/E Ratio
Valuation
21.3x
23.8x
Lower Multiple
ARX
Revenue Growth (YoY)
Growth
+6.1%
+11.5%
Higher Growth
CRVL
Operating Margin (TTM)
Profitability
3.7%
15.9%
Higher Margin
CRVL
Net Profit Margin
Profitability
5.6%
12.0%
Higher Margin
CRVL
Return on Equity (ROE)
Capital Efficiency
9.2%
30.6%
Higher ROE
CRVL
52-Week Range Position
Momentum
100% ($9–$20)
95% ($45–$90)
Stronger Trend
ARX
Beta / 30D Volatility
Risk Regime
-0.19β · 2% Vol
-0.17β · 33% Vol
Lower Realized Risk
ARX
Unified Institutional Score
Composite Signal
46.9 / 100 (HOLD)
42.6 / 100 (HOLD)
Higher Composite
ARX
Trailing 12M Revenue (USD)
Operating Scale
$2.79B
$1.01B
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.8%
25.5%
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev
N/M PEG · 4.3x EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$634M ($5.13B Net Cash)
$195M EBITDA ($8.54 Book/Sh · 30.6% ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
CRVL +8.99 pp
ARX:
+0.61%
·
CRVL:
+9.6%
3M Horizon
CRVL +28.12 pp
ARX:
+1.58%
·
CRVL:
+29.7%
6M Horizon
CRVL +22.87 pp
ARX:
+24.89%
·
CRVL:
+47.76%
1Y Horizon
ARX +25.59 pp
ARX:
+44.4%
·
CRVL:
+18.81%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARX vs CRVL. Trailing 12-month operating profitability (ARX 3.7% vs CRVL 15.9%) and valuation multiples (ARX 21.3x vs CRVL 23.8x Forward P/E) are benchmarked directly in Pillar 4 below.
ARX ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $2.79B
Gross Margin 62.8%
Op. Margin 3.7%
ROE / Fwd P/E 9.2% · 21.3x
CRVL ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $1.01B
Gross Margin 25.5%
Op. Margin 15.9%
ROE / Fwd P/E 30.6% · 23.8x
ARX
CONSOLIDATION
50d in phase · OBV NEUTRAL
Current IV
15.7%
IV Percentile
3rd %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
CRVL
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
187.6%
IV Percentile
100th %ile
Put/Call OI Skew
N/A
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
ARX Moat Profile
Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 3.7% operating margin.
OpEx & R&D Reinvestment
59.1% of Rev ($1.65B)
90D Engineering Disclosures
0 Published
CRVL Moat Profile
Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 15.9% operating margin.
OpEx & R&D Reinvestment
9.6% of Rev ($97M)
90D Engineering Disclosures
0 Published
Investor FAQ ARX vs CRVL Key Questions & Quantitative Answers
Is ARX or CRVL a better stock to buy right now?
As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Corvel Corp (CRVL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas CRVL carries 42.6/100 (HOLD) at $87.34 (23.8x Forward P/E, 15.9% operating margin). Technically, ARX sits in a Markup phase (RSI 69.8, CONSOLIDATION options structure) and CRVL sits in a Markup phase (RSI 65.7, UNCLASSIFIED options structure).
Does ARX or CRVL have stronger revenue and earnings growth?
ARX leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with CRVL at +11.5% YoY revenue growth and +24.1% YoY earnings growth on $1.01B TTM revenue (25.5% gross margin, 15.9% operating margin). On trailing 12-month operating scale, ARX generates $2.79B in USD-normalized revenue versus $1.01B for CRVL. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus 9.6% of Rev ($97M) (0 disclosures) for CRVL.
Is ARX or CRVL cheaper on valuation?
ARX screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas CRVL trades at 23.8x Forward P/E, 36.0x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (19.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus CRVL (30.6% ROE) capital efficiency.
How is options market volatility positioned on ARX vs CRVL?
In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, CRVL carries 187.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 33% Vol realized risk).
Accelerant Holdings (ARX) Research Suite
Corvel Corp (CRVL) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.